Advances in Microfluidics for the Implementation of Liquid Biopsy in Clinical Routine

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2022 Jun 27

PMID 35761007

Authors

Alexandra Teixeira

Adriana Carneiro

Paulina Piairo

Miguel Xavier

Alar Ainla

Claudia Lopes

Maria Sousa-Silva

Armando Dias

Ana S Martins

Carolina Rodrigues

Ricardo Pereira

Liliana R Pires

Sara Abalde-Cela

Lorena Dieguez

Affiliations

Soon will be listed here.

Abstract

In recent years, we have seen major advances in the field of liquid biopsy and its implementation in the clinic, mainly driven by breakthrough developments in the area of molecular biology. New developments have seen an integration of microfluidics and also biosensors in liquid biopsy systems, bringing advantages in terms of cost, sensitivity and automation. Without a doubt, the next decade will bring the clinical validation and approval of these combined solutions, which is expected to be crucial for the wide implementation of liquid biopsy systems in clinical routine.

Citing Articles

Boosting the Clinical Translation of Organ-on-a-Chip Technology.

Caballero D, Reis R, Kundu S Bioengineering (Basel). 2022; 9(10).

PMID: 36290517 PMC: 9598310. DOI: 10.3390/bioengineering9100549.

References

Mader S, Pantel K . Liquid Biopsy: Current Status and Future Perspectives. Oncol Res Treat. 2017; 40(7-8):404-408. DOI: 10.1159/000478018. View

Wu J, Hu S, Zhang L, Xin J, Sun C, Wang L . Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis. Theranostics. 2020; 10(10):4544-4556. PMC: 7150480. DOI: 10.7150/thno.40532. View

Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pelle E . Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol. 2018; 10:1758835918794630. PMC: 6116068. DOI: 10.1177/1758835918794630. View

Pantel K, Alix-Panabieres C . Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med. 2010; 16(9):398-406. DOI: 10.1016/j.molmed.2010.07.001. View

ALEXANDER R, Spriggs A . The differential diagnosis of tumour cells in circulating blood. J Clin Pathol. 1960; 13:414-24. PMC: 480111. DOI: 10.1136/jcp.13.5.414. View

Salgado I, HOPKIRK J, Long R, Ritchie A, Ritchie S, Webster D . Tumour cells in the blood. Can Med Assoc J. 1959; 81:619-22. PMC: 1831310. View

Ferreira M, Ramani V, Jeffrey S . Circulating tumor cell technologies. Mol Oncol. 2016; 10(3):374-94. PMC: 5528969. DOI: 10.1016/j.molonc.2016.01.007. View

Millner L, Linder M, Valdes Jr R . Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes. Ann Clin Lab Sci. 2013; 43(3):295-304. PMC: 5060940. View

Yap T, Lorente D, Omlin A, Olmos D, de Bono J . Circulating tumor cells: a multifunctional biomarker. Clin Cancer Res. 2014; 20(10):2553-68. DOI: 10.1158/1078-0432.CCR-13-2664. View

10.

Yu M, Stott S, Toner M, Maheswaran S, Haber D . Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011; 192(3):373-82. PMC: 3101098. DOI: 10.1083/jcb.201010021. View

11.

Neumann M, Bender S, Krahn T, Schlange T . ctDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress. Comput Struct Biotechnol J. 2018; 16:190-195. PMC: 6024152. DOI: 10.1016/j.csbj.2018.05.002. View

12.

Stoecklein N, Fischer J, Niederacher D, Terstappen L . Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution. Expert Rev Mol Diagn. 2015; 16(2):147-64. DOI: 10.1586/14737159.2016.1123095. View

13.

Paterlini-Brechot P, Benali N . Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007; 253(2):180-204. DOI: 10.1016/j.canlet.2006.12.014. View

14.

Poulet G, Massias J, Taly V . Liquid Biopsy: General Concepts. Acta Cytol. 2019; 63(6):449-455. DOI: 10.1159/000499337. View

15.

Belotti Y, Lim C . Microfluidics for Liquid Biopsies: Recent Advances, Current Challenges, and Future Directions. Anal Chem. 2021; 93(11):4727-4738. DOI: 10.1021/acs.analchem.1c00410. View

16.

Alix-Panabieres C, Pantel K . Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Cancer Discov. 2016; 6(5):479-91. DOI: 10.1158/2159-8290.CD-15-1483. View

17.

Zhang L, Riethdorf S, Wu G, Wang T, Yang K, Peng G . Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res. 2012; 18(20):5701-10. DOI: 10.1158/1078-0432.CCR-12-1587. View

18.

Yang C, Chen F, Wang S, Xiong B . Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives. Front Oncol. 2020; 9:1427. PMC: 6923205. DOI: 10.3389/fonc.2019.01427. View

19.

Li Y, Wu G, Yang W, Wang X, Duan L, Niu L . Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis. BMC Cancer. 2020; 20(1):581. PMC: 7310134. DOI: 10.1186/s12885-020-07059-x. View

20.

Busetto G, Ferro M, Del Giudice F, Antonini G, Chung B, Sperduti I . The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2017; 15(4):e661-e666. DOI: 10.1016/j.clgc.2017.01.011. View